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INTRODUCTION
A macrosomic baby has been defined in different ways 
with considerable variations of the minimum weight that 
defines macrosomia [1–3]. The most satisfactory definitions 
are a birth weight above the 90th percentile corrected 
for gestational age and sex or a birth weight over 4000g. 
Due to the variation of the minimum weight that defines 
macrosomia, reports of its incidence vary from 3% to 
15% [4]. The incidence also varies with ethnicity. Studies 
have shown that Chinese and South Asian infants are 
smaller for their gestational age [5]. Differences in birth 
weight distribution are probably due to the genetic and 
anthropometric factors [6]. Macrosomia is recognized as a 
cause of perinatal and maternal morbidity and mortality 
[4].
Risk factors for macrosomia include high maternal 
body mass index and weight gain, advanced maternal 
age, multiparity, diabetes mellitus, and gestational age 
>41 weeks [7]. However, it is well known that clinical risk 
factors alone have a very low positive predictive value [7].
The aim of this study was to determine the incidence 
of macrosomia and macrosomia-associated maternal and 
perinatal morbidity and mortality during a 6-months 
study at N’Djamena Mother and Child Hospital.
PATIENTS AND METHOD
This was a cross-sectional study covering the six 
months from January to June 2016. Our sample consisted 
of two groups: 
• The study group were mothers who delivered 
macrosomic babies. We included all live newborn 
singleton macrosomic babies who were delivered 
at or greater than 37 weeks gestation and who had 
no clinical evidence of congenital malformations. 
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• The control group were mothers who delivered a 
baby with a normal weight (ranging between 10th 
– 90th percentiles). These births were recorded 
after every macrosomia birth so there were an 
equal number of mothers in each group.
Age, parity, and birth weight were recorded. The 
outcomes of interest were perinatal and maternal 
complications. Data analysis was done by Epi info 6.0 
French. Chi-square (X2) test (p<0.05) was used to 
compare variables.
RESULTS
Out of 5,284 deliveries during the study period, 403 
babies weighed 4.0 kg and above. So the incidence of 
macrosomia was 7.6%.
Maternal characteristics
Table 1 shows that the mean maternal age and mean 
birth parity of the study group were significantly greater 
than in the control group. There were significantly more 
mothers with a previous history of macrosomia in the 
study group than in the control group.
Delivery mode
Table 2 shows that 23.1% of mothers in the study 
group had delivered by Caesarean Section versus 8.7% 
in the control group. In the study group, 73 out of 93 
(78.5%) Caesarean Sections were done as emergencies. 
The main indication was the foeto-pelvic disproportion. 
Operative vaginal are deliveries done by the vaginal route 
using episiotomy.
Maternal complications
The commonest maternal complication in the 
macrosomic group was postpartum haemorrhage, followed 
by prolonged labour and perineal laceration - mainly first- 
and second-degree laceration – see Table 3.
Perinatal outcome
Table 4 shows that the male/female ratio of the 
neonates was significantly higher among the macrosomic 
group than the control group (p=0.037). There was a 
significantly higher proportion of macrosomic babies 
with an Apgar score below seven in the first and in the 
fifth minute compared to normosomic babies (p=0.0009). 
There were 5 (1.3%) cases of shoulder dystocia in patients 
with macrosomic babies and none in the control group. 
No births injuries occurred.
There were 34 (8.4%) cases of hypoglycaemia in the 
macrosomic neonates and 11 (2.7%) in the control group. 
Among babies with hypoglycaemia 8 babies (23.5%) had 
mothers with a history of diabetes mellitus.
DISCUSSION
Incidence and risk factors
The incidence of macrosomia in this study was 7.6% 
similar to a Nigerian investigation reporting 8.1% [8]. The 
highest reported incidence is 20% in Nordic countries 
[9] while 1.5% of neonates in USA have a birth weight 
of 4.0kg [10]. These figures are influenced by race and 
local factors [8]. The pathophysiology of macrosomia is 
related to the associated maternal or foetal conditions 
of poorly controlled diabetes mellitus, maternal obesity, 
and excessive maternal weight gain. All of which have 
intermittent periods of hyperglycaemia.
Our study showed that mothers of macrosomic 
neonates were significantly older which agrees with other 
reports [8,11]. Grandmultiparity was found to be strongly 
associated with macrosomia. These findings are in keeping 
with those of Mutihir [12] and Ezegwui [8] who showed 
that there was a higher proportion of multiparity among 
mothers of macrosomic neonates.
This study demonstrated that a large  proportion 
of women delivering macrosomic babies had previous 
histories of delivering macrosomic babies. Women 
who previously delivered macrosomic babies are 5–10 
times more likely to deliver a baby considered large-for-











mean 3.4 ± 32.3 26.7± 4.1 0.02
range 43-18 44-16




Gestational age at 
delivery (weeks):
mean 41.7 ± 2.5 37.9± 2.9 0.003
range 37- 43 37- 42
Diabetes mellitus* 27 (6.7%)  5 (1.2%) 0.0001
Table 1. Maternal characteristics







Macrosomic (study group) 285(70.7) 93(23.1) 25(6.2) 403(100)
Control group 324(80.4) 35(8.7) 44(10.9) 403(100)
Table 2. Mode of delivery
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We found a greater proportion of diabetic mothers 
among the study group than in the control group. Foetal 
macrosomia in diabetic mothers has been attributed 
to poor glucose control based on using blood sugar test 
or HbA1c. Hyperglycaemia in the foetus results in the 
stimulation of the secretion of insulin, insulin like growth 
factors, growth hormone, and other growth factors, which 
in turn stimulate foetal growth and deposition of fat and 
glycogen.
Macrosomia is associated with a higher incidence of 
Caesarean Section delivery (double that among the control 
mothers) and with birth canal lacerations associated with 
vaginal delivery [14-15]. This was confirmed in this study 
with a Caesarean Section rate of 23.1% versus 8.7% in 
the control group. The risk of Caesarean Section rises 
with increasing birth weight, and the proportion of 
vaginal instrumental delivery decreases with increasing 
birth weight [16,17]. The increased Caesarean Section rate 
is a consistent finding in different countries and between 
ethnic groups, and the odds are particularly high for 
primiparous mothers [16]. In macrosomic births, the risk 
of shoulder dystocia is associated with the need for vaginal 
instrumental delivery [17].
Maternal complications
Macrosomia was strongly associated with prolonged 
pregnancy in this study. This was comparable to the 
findings of Mutihir [12] and Spellacy [14] who observed 
that macrosomic infants account for about 1% of term 
deliveries and 3-10% of post-term deliveries. Advanced 
gestational age results in a larger birth weight. This is to be 
expected as infants gain approximately 150-200g weekly 
near term. The duration of labour is more prolonged 
for women carrying macrosomic babies, and the risk is 
increased with increasing birth weight [16]. Both the first 
and second stages of labour are longer than for normosomic 
pregnancies, and arrest of descent in the second stage of 
labour is associated with macrosomia [16]. Our findings 
confirmed this with a higher rate of obstructed labour 
in the study group (19.9% versus 5.7% in the control 
group). Macrosomia had been reported as a risk factor for 
postpartum haemorrhage [17,18] - a fact confirmed in our 
study.
 Perinatal outcomes
Male infants are more likely to be macrosomic than 
female infants. Male infants are generally 150 - 200 g 
larger than female infants of the same gestational age near 
term.
Although the literature frequently and consistently 
demonstrates an increase in perinatal morbidity and 
mortality with increasing birth weight, the overall 
incidence of neonatal complications remains low [19].
We noted a higher proportion of newborns with bad 
Apgar scores in the study group compared with the control 
group. Ezegwui [8] also reported a higher proportion of 
newborns with bad Apgar scores in their study group. The 
greater the birth weight, the higher the risk of low Apgar 
scores.
More newborns with hypoglycaemia were found in the 
study group. The risk of neonatal hypoglycaemia is higher 
in heavy babies [20]. Neonates with a birth weight >4,500 
g had a seven-fold higher occurrence of hypoglycaemia, 
compared with those with an appropriate weight for 
gestation age [21]. Five cases of shoulder dystocia were 
noted in the study group versus none in the control group. 
It has been reported consistently in the literature that the 
risk of shoulder dystocia escalates with increasing birth 
weight [21]. However, the incidence of shoulder dystocia 
in different birth weight groups varies widely between 
studies [21].
CONCLUSION
This study shows that the delivery of macrosomic babies 
is unusual - at about 8% in our hospital. The risk factors 
are consistent with those reported in the literature. The 
commonest delivery mode is vaginal despite a high 
proportion of Caesarean Sections. The main maternal 
complications are postpartum haemorrhage, prolonged 
labour and perineal laceration.  Perinatal outcomes are a 










n (%) n (%)
Postpartum 
haemorrhage 64 (15.9%) 35 (8.7%) 0.003
Perineal 
laceration 18(4.4%) 7 (1.7%) 0.027
Obstructed labour
56 (13.9%) 23 (5.7%) 0 .002









Sex: male 245 (60.8%)  201 (49.9%) 0.037
Apgar score 1st 
minute (<7)
26 (6.9%) 11 (2.7%) 0.01
Apgar score 5th 
minute (<7)
15(3.7%) 5(1.2) 0 .025
Stillbirth 3 (0.7%) 11(2.7%) 0.032
Shoulder dystocia 5 (1.2%) 0 (0%) 0.025
Hypoglycemia 34(8.4%) 11(2.7%) 0.0006
Table 4. Differences in perinatal outcome
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